- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-24-0070727

About Scitus Pharma Services Private Limited
Data last updated:
Scitus Pharma Services Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 26 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2017PTC118805. Its GSTIN is 33AAZCS2737E1Z2 (Tamil Nadu).
The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹14.52 Cr. It is led by directors including Ayyavu Rajavel and Shanmugam Muthusamy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.45 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹3.88 Cr (net margin 8.9%) and EBITDA of ₹8.76 Cr (EBITDA margin 20.2%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 35% over five years.
The company has about 157 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Scitus. Court records list 9 cases involving the company, including 9 filed by the company; 1 case is pending. The company has 10 deals on record (5 funding rounds, 3 rights issues, 2 secondary share transfers), with disclosed funding of ₹10.7 Cr; the latest was in June 2022. Its 4 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 1 larger and 3 smaller; the largest is Vivo Bio Tech Limited with revenue of ₹45.49 Cr. The company has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 1 overdue payment to 1 micro and small supplier.
Scitus Pharma Services Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-24-0070727). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website scituspharma.com.
Company details
Recognitions & Rankings of Scitus Pharma Services
Contact details
Scitus Pharma Services Private Limited's registered office is in Chennai, Tamil Nadu. Its website is scituspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressModule No.24 32 33 34 35 36&37 2nd Floor SIDCO Complex SIDCO Industrial Estate Thirumaz, Hisai, Chennai, Tamil Nadu, India – 600124
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Scitus Pharma Services Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Scitus Pharma Services operates one associated brand: Scitus. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides contract research services including clinical trials and bioanalytical studies. | scituspharma.com |
Business activity
The main business activity of Scitus Pharma Services is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Scitus Pharma Services Private Limited, buy the company report.
Financials of Scitus Pharma Services Private Limited
FY 2024 filings availableScitus Pharma Services Private Limited reported revenue of ₹43.45 Cr (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 35% over five years, including 17% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.76 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.88 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.2% | ||||
| Net Profit Margin | 8.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Scitus Pharma Services Private Limited, buy the company report.
Board of directors of Scitus Pharma Services Private Limited
Scitus Pharma Services has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayyavu Rajavel Also directs: Nuray Chemicals Private Limited, Saimirra Innopharm Private Limited, Esjay Pharma Private Limited and 5 more | Director | 26 Sep 2017 | 9 Years 1 Months | Current |
| Shanmugam Muthusamy Also directs: Annamar Pharma LLP, Nuray Chemicals Private Limited, Saimirra Innopharm Private Limited and 5 more | Director | 26 Sep 2017 | 9 Years 1 Months | Current |
| Sankar | Director | 01 Oct 2021 | 5 Years 1 Months | Current |
| Sruthi Nandhaa Shanmugam | Director | 01 Oct 2021 | 5 Years 1 Months | Current |
Peer comparison
Scitus Pharma Services Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vivo Bio Tech Limited | ₹45.49 Cr (FY 2024) | -13.0% | Hyderabad, Telangana, India | |||
| Scitus Pharma Services Private Limitedthis company | ₹43.45 Cr (FY 2025) | ₹3.88 Cr | 8.9% | 17.0% | 157 | Chennai, Tamil Nadu, India |
| Energon Labs Private Limited | ₹42.42 Cr (FY 2024) | 48.0% | Hyderabad, Telangana, India | |||
| Enem Nostrum Remedies Private Limited | ₹42.33 Cr (FY 2025) | -13.0% | Mumbai, Maharashtra, India | |||
| Onecell Diagnostics India Private Limited | ₹41.91 Cr (FY 2025) | 95.0% | Pune, Maharashtra, India |
To see the full peer comparison of Scitus Pharma Services Private Limited, buy the company report.
Auditor
Scitus Pharma Services Private Limited is audited by SENTHIL RAJA AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SENTHIL RAJA AND ASSOCIATES | FY 2023 | 012995S |
Shareholding
The shareholding of Scitus Pharma Services Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Scitus Pharma Services Private Limited, buy the company report.
Deals & funding
Scitus Pharma Services Private Limited has 10 deals on record (5 funding rounds, 3 rights issues, 2 secondary share transfers), with disclosed funding of ₹10.7 Cr; the latest was in June 2022.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2022 | Funding round | ₹30 Lakh | Investors: an individual |
| Jun 2020 | Funding round | ₹3.4 Cr | Investors: 3 individuals |
| May 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Jul 2019 | Funding round | ₹3.2 Cr | Investors: 3 individuals |
| Jan 2019 | Funding round | ₹2.8 Cr | Investors: 2 individuals |
To see the full deal history of Scitus Pharma Services Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Scitus Pharma Services Private Limited has 9 court cases on record: 9 filed by Scitus Pharma Services. 1 case is pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 0 | 1 |
Cases on record (4 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kancheepuram, Tamil Nadu | Criminal complaint | Filed by the company against M/S. Adlar Pneumatic Pvt. Ltd and 2 others | Pending |
| District court, Chengalpattu, Tamil Nadu | Criminal complaint | Filed by the company against M/S. Adlar Pneumatic Pvt. Ltd | Disposed |
| District court, Chengalpattu, Tamil Nadu | Criminal complaint | Filed by the company against M/S. Adlar Pneumatic Pvt. Ltd | Disposed |
| District court, Kancheepuram, Tamil Nadu | Criminal miscellaneous application | Filed by the company | Disposed |
To see the full case history of Scitus Pharma Services Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Scitus Pharma Services Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vivan Life Sciences Private Limited |
To see the full MSME payment records of Scitus Pharma Services Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Scitus Pharma Services Private Limited has a workforce of 157 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Scitus Pharma Services has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAZCS2737E1Z2 | Tamil Nadu | Active | 25 Oct 2017 |
To see the full GST registrations and return filing status of Scitus Pharma Services Private Limited, buy the company report.
Recent activity
Scitus Pharma Services Private Limited has 7 board changes on record since 2017: 4 appointments and 3 cessations. The latest: Sankar ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Scitus Pharma Services is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 26 September 2017 (9+ years old) and is registered under CIN U74999TN2017PTC118805.
Scitus Pharma Services has 4 current directors:
- Ayyavu Rajavel - Director
- Shanmugam Muthusamy - Director
- Sankar - Director
- Sruthi Nandhaa Shanmugam - Director
The latest financial statements of Scitus Pharma Services on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Scitus Pharma Services is 33AAZCS2737E1Z2, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Scitus Pharma Services is U74999TN2017PTC118805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scitus Pharma Services has 9 court cases on record: 9 filed by the company. 1 is pending.
Scitus Pharma Services was incorporated on 26 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.
Scitus Pharma Services has 10 deals on record (5 funding rounds, 3 rights issues, 2 secondary share transfers), with disclosed funding of ₹10.7 Cr; the latest was in June 2022.
The peers of Scitus Pharma Services by revenue are Vivo Bio Tech Limited, Energon Labs Private Limited, Enem Nostrum Remedies Private Limited, Onecell Diagnostics India Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Sankar ceased to be Additional Director on 30 Nov 2021. Sruthi Nandhaa Shanmugam ceased to be Additional Director on 30 Nov 2021. Sankar was appointed as Director on 01 Oct 2021. Scitus Pharma Services has 7 board changes on record in total.
Yes, Scitus Pharma Services is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-24-0070727).
Scitus Pharma Services has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 04 Jun 2019.

